Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta Zuckerman, Adina Bar-Chaim, Yitshak Kreiss, Gili Regev-Yochay, Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta Zuckerman, Adina Bar-Chaim, Yitshak Kreiss, Gili Regev-Yochay

Abstract

Background: Despite the high efficacy of the BNT162b2 messenger RNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough infections have been reported, including infections among health care workers. Data are needed to characterize these infections and define correlates of breakthrough and infectivity.

Methods: At the largest medical center in Israel, we identified breakthrough infections by performing extensive evaluations of health care workers who were symptomatic (including mild symptoms) or had known infection exposure. These evaluations included epidemiologic investigations, repeat reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays, antigen-detecting rapid diagnostic testing (Ag-RDT), serologic assays, and genomic sequencing. Correlates of breakthrough infection were assessed in a case-control analysis. We matched patients with breakthrough infection who had antibody titers obtained within a week before SARS-CoV-2 detection (peri-infection period) with four to five uninfected controls and used generalized estimating equations to predict the geometric mean titers among cases and controls and the ratio between the titers in the two groups. We also assessed the correlation between neutralizing antibody titers and N gene cycle threshold (Ct) values with respect to infectivity.

Results: Among 1497 fully vaccinated health care workers for whom RT-PCR data were available, 39 SARS-CoV-2 breakthrough infections were documented. Neutralizing antibody titers in case patients during the peri-infection period were lower than those in matched uninfected controls (case-to-control ratio, 0.361; 95% confidence interval, 0.165 to 0.787). Higher peri-infection neutralizing antibody titers were associated with lower infectivity (higher Ct values). Most breakthrough cases were mild or asymptomatic, although 19% had persistent symptoms (>6 weeks). The B.1.1.7 (alpha) variant was found in 85% of samples tested. A total of 74% of case patients had a high viral load (Ct value, <30) at some point during their infection; however, of these patients, only 17 (59%) had a positive result on concurrent Ag-RDT. No secondary infections were documented.

Conclusions: Among fully vaccinated health care workers, the occurrence of breakthrough infections with SARS-CoV-2 was correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

Copyright © 2021 Massachusetts Medical Society.

Figures

Figure 1. Cases and Controls in Study…
Figure 1. Cases and Controls in Study Design.
Shown is the chronologic sequence of events for health care workers who were included in the case–control study. There was some overlap between the cases and controls, since some of the workers with breakthrough cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection had also been included in the earlier serologic analysis from which control samples were selected. A case–control ratio of 1:4 or 1:5 was selected to maximize the statistical power of the study. RT-PCR denotes reverse transcriptase–polymerase chain reaction.
Figure 2. Neutralizing Antibody and IgG Titers…
Figure 2. Neutralizing Antibody and IgG Titers among Cases and Controls, According to Timing.
Among the 39 fully vaccinated health care workers who had breakthrough infection with SARS-CoV-2, shown are the neutralizing antibody titers during the peri-infection period (within a week before SARS-CoV-2 detection) (Panel A) and the peak titers within 1 month after the second dose (Panel B), as compared with matched controls. Also shown are IgG titers during the peri-infection period (Panel C) and peak titers (Panel D) in the two groups. Each case of breakthrough infection was matched with 4 to 5 controls according to sex, age, immunosuppression status, and timing of serologic testing after the second vaccine dose. In each panel, the horizontal bars indicate the mean geometric titers and the 𝙸 bars indicate 95% confidence intervals. Symptomatic cases, which were all mild and did not require hospitalization, are indicated in red.
Figure 3. Correlation between Neutralizing Antibody Titer…
Figure 3. Correlation between Neutralizing Antibody Titer and N Gene Cycle Threshold as Indication of Infectivity.
The results of antigen-detecting (Ag) rapid diagnostic testing for the presence of SARS-CoV-2 are shown, along with neutralizing antibody titers and N gene cycle threshold (Ct) values in 22 fully vaccinated health care workers with breakthrough infection for whom data were available (slope of regression line, 171.2; 95% CI, 62.9 to 279.4).

References

    1. Haas EJ, Angulo FJ, McLaughlin JM, et al.Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021;397:1819-1829.
    1. Polack FP, Thomas SJ, Kitchin N, et al.Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-2615.
    1. Dagan N, Barda N, Kepten E, et al.BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med 2021;384:1412-1423.
    1. Regev-Yochay G, Amit S, Bergwerk M, et al.Decreased infectivity following BNT162b2 vaccination: a prospective cohort study in Israel. Lancet Reg Health Eur 2021;7:100150-100150.
    1. Petter E, Mor O, Zuckerman N, et al.Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2. February8, 2021. (). preprint.
    1. Stephenson J. COVID-19 vaccinations in nursing home residents and staff give robust protection, though breakthrough infections still possible. JAMA Health Forum 2021;2(4):e211195-e211195 ().
    1. Tyagi K, Ghosh A, Nair D, et al.Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes Metab Syndr 2021;15:1007-1008.
    1. Hacisuleyman E, Hale C, Saito Y, et al.Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 2021;384:2212-2218.
    1. Krammer F. Correlates of protection from SARS-CoV-2 infection. Lancet 2021;397:1421-1423.
    1. Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet 2021;397:875-877.
    1. Lustig Y, Sapir E, Regev-Yochay G, et al.BNT162b2 vaccine-induced immune responses and dynamics vary among age groups, sex and co-morbidities: a longitudinal prospective cohort study. March4, 2021. (). preprint.
    1. Jefferson T, Spencer EA, Brassey J, Heneghan C. Viral cultures for COVID-19 infectious potential assessment — a systematic review. Clin Infect Dis 2020December3(Epub ahead of print).
    1. Singanayagam A, Patel M, Charlett A, et al.Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 2020;25:2001483-2001483.
    1. Zuckerman NS, Pando R, Bucris E, et al.Comprehensive analyses of SARS-CoV-2 transmission in a public health virology laboratory. Viruses 2020;12:854-854.
    1. Dieterle ME, Haslwanter D, Bortz RH III, et al.A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe 2020;28(3):486-496.e6.
    1. Kustin T, Harel N, Finkel U, et al.Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med 2021June14(Epub ahead of print).
    1. Pratò S, Paladino ME, Riva MA, Deni M, Belingheri M. SARS-CoV-2 transmission risk to household and family contacts by vaccinated healthcare workers. J Occup Environ Med 2021;63(7):e474-e476.
    1. Shah ASV, Gribben C, Bishop J, et al.Effect of vaccination on transmission of COVID-19: an observational study in healthcare workers and their households. March21, 2021. (). preprint.
    1. Hall VJ, Foulkes S, Charlett A, et al.SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet 2021;397:1459-1469.
    1. Khoury DS, Cromer D, Reynaldi A, et al.Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 2021May17(Epub ahead of print).
    1. Earle KA, Ambrosino DM, Fiore-Gartland A, et al.Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 2021;39:4423-4428..
    1. Criscuolo E, Diotti RA, Strollo M, et al.Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects. J Med Virol 2021;93:2160-2167.
    1. Jacobson KB, Pinsky BA, Rath MEM, et -vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center. April24, 2021. (). preprint.
    1. Thompson CN, Hughes S, Ngai S, et al.Rapid emergence and epidemiologic characteristics of the SARS-CoV-2 B.1.526 variant — New York City, New York, January 1–April 5, 2021. MMWR Morb Mortal Wkly Rep 2021;70:712-716.
    1. Bouton TC, Lodi S, Turcinovic J, et al.COVID-19 vaccine impact on rates of SARS-CoV-2 cases and post vaccination strain sequences among healthcare workers at an urban academic medical center: a prospective cohort study. April27, 2021. (). preprint.
    1. Philomina J B, Jolly B, John N, et al.Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India. J Infect 2021May25(Epub ahead of print).

Source: PubMed

3
Předplatit